Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Julio Manuel Rios de la Rosa"'
Autor:
Alice Spadea, Annalisa Tirella, Julio Manuel Rios de la Rosa, Enrique Lallana, Manal Mehibel, Brian Telfer, Nicola Tirelli, Margaret Jayne Lawrence, Kaye J. Williams, Ian J. Stratford, Marianne Ashford
Publikováno v:
Pharmaceutics, Vol 16, Iss 10, p 1286 (2024)
Background/Objectives: Conventional anticancer therapies often lack specificity, targeting both cancerous and normal cells, which reduces efficacy and leads to undesired off-target effects. An additional challenge is the presence of hypoxic regions i
Externí odkaz:
https://doaj.org/article/a3b8c5c8ac114761af6bae85f5b0e888
Autor:
Spadea, Alice1,2,3 (AUTHOR) annalisa.tirella@unitn.it, Tirella, Annalisa3,4 (AUTHOR) manal.mehibel@abbvie.com, Rios de la Rosa, Julio Manuel1,3,5 (AUTHOR) ian.j.stratford@manchester.ac.uk, Lallana, Enrique1,3,6 (AUTHOR), Mehibel, Manal3,7 (AUTHOR), Telfer, Brian3 (AUTHOR), Tirelli, Nicola3,8 (AUTHOR), Lawrence, Margaret Jayne1,3 (AUTHOR), Williams, Kaye J.3 (AUTHOR), Stratford, Ian J.3 (AUTHOR), Ashford, Marianne9 (AUTHOR) marianne.ashford@astrazeneca.com
Publikováno v:
Pharmaceutics. Oct2024, Vol. 16 Issue 10, p1286. 18p.
Autor:
Doyle, Dara (AUTHOR), Pérez, Irene García (AUTHOR)
Publikováno v:
Bloomberg.com. 12/10/2018, pN.PAG-N.PAG. 1p.